To get around the problem of addicts failing to follow a drug regimen, DrugAbuse Sciences is developing a controlled-release version of naltrexone that requires only a monthly injection.
In 1994 Pouletty formed his third biotech startup and named it DrugAbuse Sciences, basing it in Paris and Los Altos, Calif. and devoting it solely to developing treatments for alcohol and drug addiction.